From the outside looking in, psychedelics had a monumental year. Mainstream media has been talking about it – telling stories and building momentum. The stigma is slowly breaking down due to this momentum.

But if you look beyond the surface, you’ll see that 2022 did not serve those that are participating in this industry. Valuations shot down as stock prices corrected. Overall, there is a sense that capital is drying up.

That said, there are still plenty of storylines to follow. There is growth as a whole, you just have to know where to look.

You must have PRO to access this content
or purchase this report individually.

Buy Now $499.99